Literature DB >> 3407822

Setting AIDS priorities: the need for a closer alliance of public health and clinical approaches toward the control of AIDS.

K Henry1.   

Abstract

The approach to the acquired immune deficiency syndrome (AIDS) taken by public health departments and clinicians varies. Public health programs often neglect the human side of AIDS while clinicians often overlook public health issues. Current research on AIDS has failed to address many fundamental questions including: the biology of the human immunodeficiency virus (HIV) in semen; whether present antiretroviral therapy has any effect on sexual infectivity; and whether adequate counseling was given to persons in HIV discordant partner studies. These unanswered basic questions highlight how research efforts framed from clinical, basic science, or public health viewpoints may have too narrow a focus. Three suggestions are made: 1) additional studies about the biology of HIV in the genital tract need to be conducted; 2) clinical trials studying drug therapy of HIV infection need to assess effect on HIV in the genital tract; 3) clinicians involved in studies and care of HIV infection need to implement educational strategies minimizing transmission of HIV from their patients. More interaction between public health and clinical approaches toward AIDS is needed.

Entities:  

Mesh:

Year:  1988        PMID: 3407822      PMCID: PMC1349396          DOI: 10.2105/ajph.78.9.1210

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Elimination of toxicity and enhanced cytomegalovirus detection in cell cultures inoculated with semen from patients with acquired immunodeficiency syndrome.

Authors:  C L Howell; M J Miller; D A Bruckner
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  AIDS in Africa: an epidemiologic paradigm.

Authors:  T C Quinn; J M Mann; J W Curran; P Piot
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

3.  Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.

Authors:  M W Vogt; D J Witt; D E Craven; R Byington; D F Crawford; R T Schooley; M S Hirsch
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

4.  Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus.

Authors:  C B Wofsy; J B Cohen; L B Hauer; N S Padian; B A Michaelis; L A Evans; J A Levy
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Stigmatization of AIDS patients by physicians.

Authors:  J A Kelly; J S St Lawrence; S Smith; H V Hood; D J Cook
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

Review 6.  Prevention of AIDS and HIV infection: needs and priorities for epidemiologic research.

Authors:  J R Allen; J W Curran
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

7.  Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.

Authors:  M A Fischl; G M Dickinson; G B Scott; N Klimas; M A Fletcher; W Parks
Journal:  JAMA       Date:  1987-02-06       Impact factor: 56.272

8.  Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission.

Authors:  R R Redfield; P D Markham; S Z Salahuddin; D C Wright; M G Sarngadharan; R C Gallo
Journal:  JAMA       Date:  1985-10-18       Impact factor: 56.272

9.  HTLV-III in cells cultured from semen of two patients with AIDS.

Authors:  D Zagury; J Bernard; J Leibowitch; B Safai; J E Groopman; M Feldman; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

10.  Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome.

Authors:  M W Vogt; D J Witt; D E Craven; R Byington; D F Crawford; M S Hutchinson; R T Schooley; M S Hirsch
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.